Acceptability of Fluzone Intradermal Vaccine to Patients and Vaccine Administrators
Completed
Conditions studied: Patient Response to Fluzone ID Vaccine
In brief
To assess the acceptance of the Fluzone Intradermal (ID)vaccine in adults and vaccine administrators in the United States. Patients completed 2 surveys, one immediately post-vaccination and one seven days later, that documented demographics and assessed their injection pain, injection anxiety, speed of injection, overall satisfaction, and preference for next year's vaccine. Vaccine administrators completed one survey assessing ease of vaccine preparation and administration, time required to administer, and safety/risk of needle stick injury for patient and administrator.
Key facts
- Study ID
- NCT01716130
- Run by
- Touro University, California
- People needed
- 249
- Starts
- 2011-10-01
- Expected to finish
- 2011-11-01
- Last updated by the study team
- 2012-10-29
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: accepted.
Where it is running
- Touro University California — Vallejo, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.